Xeris Pharmaceuticals' Series C - III Round

Xeris Pharmaceuticals raised a round of funding on May 17, 2017.

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…

Articles about Xeris Pharmaceuticals' Series C - III Round: